USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: SCHRODINGER, INC.
City: PORTLAND
State: OR
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,080,447.00 11
SBIR Phase II $3,447,069.00 5

Award List:

PSEUDOSPECTRAL METHODS FOR QUANTUM BIOCHEMISTRY

Award Year / Program / Phase: 1991 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ringnalda, Murco N , Principal Investigator
Award Amount: $50,000.00

PSEUDOSPECTRAL QUANTUM CHEMISTRY FOR PERIODIC SYSTEMS

Award Year / Program / Phase: 1992 / SBIR / Phase I
Agency: DOE
Principal Investigator:
Award Amount: $50,000.00
Abstract:
The pseudospectral method (originally developed for fluid dynamics simulations) has been adapted to the calculation of quantum chemical wavefunctions and properties for molecular systems, resulting in computational costs reduced by an order of magnitude. this novel method is being extended to treat… More

PSEUDOSPECTRAL METHODS FOR QUANTUM BIOCHEMISTRY

Award Year / Program / Phase: 1993 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ringnalda, Murco N , Principal Investigator
Award Amount: $500,000.00
Abstract:
Recent developments in the research groups of r. friesner (columbia university) and w. goddard (caltech) have led to the development of the pseudospectral generalized valence bond (psgvb) electronic structure method, which has the potential to decrease by several orders of magnitude the costs of… More

PARALLELIZATION OF PSEUDOSPECTRAL ALGORITHMS FOR ELECTRONIC STRUCTURE CALCULATIONS

Award Year / Program / Phase: 1994 / SBIR / Phase I
Agency: DOE
Principal Investigator: Dr Murco N Ringnalda
Award Amount: $74,880.00
Abstract:
Electronic, structure programs are becoming an increasingly powerful tool for solving chemical and biological problems without costly experiments, but in order to use current and future computer hardware to maximal advantage, they must be parallelized efficiently. the pseudospectral (ps) approach… More

New methods for Quantum Biochemistry in Solution

Award Year / Program / Phase: 1994 / SBIR / Phase I
Agency: HHS
Principal Investigator: Murco Ringnalda
Award Amount: $79,750.00

Parallel Component Software for Efficient Density Functional Theory Calculations

Award Year / Program / Phase: 1995 / SBIR / Phase I
Agency: DOC
Principal Investigator: Dr. Jean-Marc Langlois , Senior Scientist
Award Amount: $49,987.00
Abstract:
Experimental studies of thin films are a major industrial endeavor, since these films are crucial to applications including tribologicl coatings used by automobile manufacturers and others, high resolution flat panel displays, and growth of selective far infrared detectors. Because these… More

New methods for Quantum Biochemistry in Solution

Award Year / Program / Phase: 1996 / SBIR / Phase II
Agency: HHS
Principal Investigator: Murco Ringnalda
Award Amount: $750,000.00
Abstract:
Ab initio quantum chemistry methods are now both accurate and practical when applied to gasphase calculations, but useful applications of these techniques to most biological and biomedicalprocesses will not be feasible until they can be used for realistic and precise calculations of solvatedsystems.… More

POLARIZABLE FORCE FIELDS FOR PEPTIDES AND PROTEINS

Award Year / Program / Phase: 1996 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $100,000.00

Novel Electron Correlation Methods: Multiconfigurational Density Functional Theory

Award Year / Program / Phase: 1997 / SBIR / Phase I
Agency / Branch: DOD / USAF
Principal Investigator: Murco N. Ringnalda
Award Amount: $100,000.00
Abstract:
This Small Business Innovation Research Phase I project will result in a multiconfiguratinal density functional approach to electronic structure problems that combines ab initio generalized valence bond (GVB) and restricted configuration interaction (RCI) techniques with density functional theory… More

SBIR Phase I: Software for Fast and Accurate Calculations onTransition-Metal Systems

Award Year / Program / Phase: 1997 / SBIR / Phase I
Agency: NSF
Principal Investigator: Murco Ringnalda
Award Amount: $75,000.00

Software for Fast and Accurate Calculations on Transition-Metal Systems

Award Year / Program / Phase: 1998 / SBIR / Phase II
Agency: NSF
Principal Investigator: Murco Ringnalda
Award Amount: $387,608.00

N/A

Award Year / Program / Phase: 1999 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $749,998.00

Accurate Thermochemistry for Large Systems

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: NSF
Principal Investigator: Robert Murphy
Award Amount: $100,000.00

Modeling Metal-Containing Biological Systems

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Robert B. Murphy
Award Amount: $99,987.00
Abstract:
DESCRIPTION (provided by applicant): Schrodinger's QSite is a mixed quantum mechanics/molecular mechanics (QM/MM) program specifically targeted to biological applications. QSite is based on a pairing of Jaguar [with its fast pseudospectral implementation of density functional theory (DFT) and other… More

Commercial Software for Modeling of G Protein-Coupled Receptors

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $300,843.00
Abstract:
DESCRIPTION (provided by applicant): Dysfunction of G protein-coupled receptors (GPCRs) results in diseases as diverse as Alzheimer's, Parkinson's, diabetes, dwarfism, color blindness, retina pigmentosa and asthma. GPCRs are also involved in depression, sc hizophrenia, sleeplessness, hypertension,… More

Commercial Software for Modeling of G Protein-Coupled Receptors

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ramy Farid
Award Amount: $1,059,463.00
Abstract:
DESCRIPTION (provided by applicant): Dysfunction of G protein-coupled receptors (GPCRs) results in diseases as diverse as Alzheimer's, Parkinson's, diabetes, dwarfism, color blindness, retina pigmentosa and asthma. GPCRs are also involved in depression, sc hizophrenia, sleeplessness, hypertension,… More